NanoVibronix and Marathon Medical to Provide PainShield to VA Hospitals and the DOJ

Xenter, Inc. Appoints 4 Industry Leaders to Board of Directors; Closes $12M Series A

Xenter’s first product, which the company will announce shortly, is a medical device that not only combines the function of multiple existing devices but will also revolutionize the field of interventional medicine by producing valuable Physical Intelligence™ data and enabling advanced Artificial Intelligence solutions, leading to improved patient outcomes while reducing the cost, complexity and invasiveness of cardiac procedures.

Indivumed Partners with Oslo University Hospital to Advance Cancer Research

By scanning high-resolution images of haematoxylin and eosin-stained tumor section slides for all IndivuType cases, Indivumed will be able to leverage an entirely new dimension of data in the coming months.

Harold Hill Joins NeuX Technologies as Director of Corporate Accounts

Harold Hill is a retired Special Forces Medic, serving 26 years, and led the medical department for a Special Missions Unit within the United States Special Operations Command

Today NanoVibronix, Inc., a medical device company that produces the PainShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic therapeutic device, announced on August 18th, 2019, PainShield, and PainShield Supplies were added to the Federal Supply Schedule through NanoVibronix’ relationship with Marathon Medical, a Service Disabled Veteran Owned Small Business (SDVOSB) headquartered in Aurora, Colorado. Accordingly, Marathon Medical can now sell PainShield and related supplies to the Veterans Health Administration, the largest integrated health care system in the United States, providing care at 1,255 health care facilities, including 170 VA Medical Centers and 1,074 outpatient sites of care of varying complexity,  and the U.S. Department of Justice to combat pain and provide an opioid alternative pain management system.

The Veterans Health Administration (VA) has launched an Opioid Safety Initiative (OSI), designed to address the growing epidemic of opioid misuse and opioid use disorder in America. It is estimated that chronic pain is a common condition for nearly 20 million Veterans, and more than 50% of the nearly nine million Veterans enrolled in the VA health care system are receiving treatment each year for chronic pain. PainShield provides a proven, opioid-free alternative to relieve pain for Veterans and others, in-line with the goals of this initiative.

Brian Murphy, CEO of NanoVibronix Inc. said, “Our collaboration with Marathon Medical, a leading veteran-owned business, will help put proven solutions in the hands of our Veterans to help address chronic pain while avoiding the dangers of opioids. Securing a Federal Supply Schedule number was a key step in this effort, creating a new and exciting market for our technology.”



Subscribe to Medical Device News Magazine

Related Articles